The use of magnetic resonance spectroscopy in the evaluation of the natural history of multiple sclerosis

D. L. Arnold, J. S. Wolinsky, P. M. Matthews, A. Falini

Research output: Contribution to journalArticle

Abstract

Magnetic resonance spectroscopic imaging (MRSI) can be used to define specific chemical-pathological changes in the brain of patients with multiple sclerosis. Magnetic resonance spectroscopy offers promise for improved definition of the nature of individual lesions, the dynamics of their evolution, their effects on normal appearing white matter, and their relation to clinical disability. Combined multimodal MRSI studies of the brains of patients with multiple sclerosis therefore soon may provide efficient, specific, and quantitative new approaches to assessment of drug effects in therapeutic trials.

Original languageEnglish
JournalJournal of Neurology, Neurosurgery and Psychiatry
Volume64
Issue numberSUPPL. 1
Publication statusPublished - May 1998

Fingerprint

Multiple Sclerosis
Magnetic Resonance Spectroscopy
Magnetic Resonance Imaging
Brain
Therapeutic Uses
Pharmaceutical Preparations
White Matter

Keywords

  • Multiple sclerosis
  • Nuclear magnetic resonance spectroscopy

ASJC Scopus subject areas

  • Neuropsychology and Physiological Psychology
  • Neuroscience(all)
  • Psychiatry and Mental health

Cite this

The use of magnetic resonance spectroscopy in the evaluation of the natural history of multiple sclerosis. / Arnold, D. L.; Wolinsky, J. S.; Matthews, P. M.; Falini, A.

In: Journal of Neurology, Neurosurgery and Psychiatry, Vol. 64, No. SUPPL. 1, 05.1998.

Research output: Contribution to journalArticle

@article{ecc1f03f63f74351b7f6644b7c388d34,
title = "The use of magnetic resonance spectroscopy in the evaluation of the natural history of multiple sclerosis",
abstract = "Magnetic resonance spectroscopic imaging (MRSI) can be used to define specific chemical-pathological changes in the brain of patients with multiple sclerosis. Magnetic resonance spectroscopy offers promise for improved definition of the nature of individual lesions, the dynamics of their evolution, their effects on normal appearing white matter, and their relation to clinical disability. Combined multimodal MRSI studies of the brains of patients with multiple sclerosis therefore soon may provide efficient, specific, and quantitative new approaches to assessment of drug effects in therapeutic trials.",
keywords = "Multiple sclerosis, Nuclear magnetic resonance spectroscopy",
author = "Arnold, {D. L.} and Wolinsky, {J. S.} and Matthews, {P. M.} and A. Falini",
year = "1998",
month = "5",
language = "English",
volume = "64",
journal = "Journal of Neurology, Neurosurgery and Psychiatry",
issn = "0022-3050",
publisher = "BMJ Publishing Group",
number = "SUPPL. 1",

}

TY - JOUR

T1 - The use of magnetic resonance spectroscopy in the evaluation of the natural history of multiple sclerosis

AU - Arnold, D. L.

AU - Wolinsky, J. S.

AU - Matthews, P. M.

AU - Falini, A.

PY - 1998/5

Y1 - 1998/5

N2 - Magnetic resonance spectroscopic imaging (MRSI) can be used to define specific chemical-pathological changes in the brain of patients with multiple sclerosis. Magnetic resonance spectroscopy offers promise for improved definition of the nature of individual lesions, the dynamics of their evolution, their effects on normal appearing white matter, and their relation to clinical disability. Combined multimodal MRSI studies of the brains of patients with multiple sclerosis therefore soon may provide efficient, specific, and quantitative new approaches to assessment of drug effects in therapeutic trials.

AB - Magnetic resonance spectroscopic imaging (MRSI) can be used to define specific chemical-pathological changes in the brain of patients with multiple sclerosis. Magnetic resonance spectroscopy offers promise for improved definition of the nature of individual lesions, the dynamics of their evolution, their effects on normal appearing white matter, and their relation to clinical disability. Combined multimodal MRSI studies of the brains of patients with multiple sclerosis therefore soon may provide efficient, specific, and quantitative new approaches to assessment of drug effects in therapeutic trials.

KW - Multiple sclerosis

KW - Nuclear magnetic resonance spectroscopy

UR - http://www.scopus.com/inward/record.url?scp=0031778180&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031778180&partnerID=8YFLogxK

M3 - Article

C2 - 9647294

AN - SCOPUS:0031778180

VL - 64

JO - Journal of Neurology, Neurosurgery and Psychiatry

JF - Journal of Neurology, Neurosurgery and Psychiatry

SN - 0022-3050

IS - SUPPL. 1

ER -